BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 19135657)

  • 1. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Hilário SG; Bozzini N; Borsari R; Baracat EC
    Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
    Duhan N; Madaan S; Sen J
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis.
    Alborzi S; Hamedi B; Omidvar A; Dehbashi S; Alborzi S; Alborzi M
    Arch Gynecol Obstet; 2011 Jul; 284(1):105-10. PubMed ID: 20661580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of symptomatic uterine leiomyoma with letrozole.
    Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
    Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
    Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.
    Gregoriou O; Bakas P; Grigoriadis C; Creatsa M; Hassiakos D; Creatsas G
    Fertil Steril; 2012 Jul; 98(1):48-51. PubMed ID: 22579129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anastrazole on symptomatic uterine leiomyomata.
    Varelas FK; Papanicolaou AN; Vavatsi-Christaki N; Makedos GA; Vlassis GD
    Obstet Gynecol; 2007 Sep; 110(3):643-9. PubMed ID: 17766612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
    Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
    Kimura F; Takahashi K; Takebayashi K; Fujiwara M; Kita N; Noda Y; Harada N
    Fertil Steril; 2007 Jun; 87(6):1468.e9-12. PubMed ID: 17222833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial.
    Garcia-Velasco JA; Quea G; Piró M; Mayoral M; Ruiz M; Toribio M; Requena A
    Fertil Steril; 2009 Jul; 92(1):222-5. PubMed ID: 18710719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
    Verma A; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):112-5. PubMed ID: 19233536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.